Vildagliptin - Wikipedia, the free encyclopedia
^By Avery Johnson and Ron Winslow 2180 words 2 July 2008 The Wall Street Journal Europe ^ EU approves Novartis diabetes drug Galvus. Reuters, February 01, 2008 ^ EU approves Novartis's ...
Novartis - Wikipedia, the free encyclopedia
Novartis had challenged a law that allows India to refuse to recognize a patent for an ... patented medicines - was a threat to people suffering from cancer, HIV and AIDS, diabetes ...
Novartis Brings "diabetes To Light", Unites With International ...
Novartis brings diabetes to light and unites with the International Diabetes Federation (IDF) by taking part in the IDF's Monument Challenge and lighting the corporate headquarters ...
Novartis Diabetes Drug Delayed - WSJ.com
Novartis said it has found new liver-safety problems with high doses of its diabetes medicine Galvus, delaying the major drug's path to market in Europe and raising further ...
Novartis Galvus Delay - Companies * Europe * News * Story - CNBC.com
Novartis has found safety problems in higher doses of its key Galvus diabetes drug and will revise prescribing recommendations before launching in Europe.
Broad, Novartis announce diabetes initiative - MIT News Office
The Novartis and the Broad Institute of MIT and Harvard have announced a joint project to decipher the genetic causes of type 2 diabetes. The team plans to make its findings freely ...
Diabetes Clinical Trial Information
Clinical trials are scientific research studies designed to find better ways to treat or prevent diseases. Our goal is to help you make an educated decision about participating in ...
Novartis brings “diabetes to light,” unites with International ...
Diabetes is one of the world’s greatest health challenges and is associated with many serious conditions, including cardiovascular disease. Novartis is committed to raising the ...
Novartis to share diabetes research - The Boston Globe
Swiss drug giant Novartis SA said yesterday it is spending $4 million to fund scientists performing diabetes research at Harvard University, the Massachusetts Institute of ...
Europe Panel Backs Novartis Diabetes Drug - WSJ.com
A diabetes medicine produced by Novartis received a positive opinion from European authorities after the drug maker changed its prescribing recommendations amid liver-safety ...
Novartis Announces New Award in Diabetes
EAST HANOVER, N.J., Oct. 12 /PRNewswire/ -- Novartis is pleased to announce the establishment of the first Novartis Award in Diabetes. The award will be presented in two ...
Novartis Pharmaceuticals Corporation
Announcement. Diversity Inc recognizes Novartis as one of the top 50 companies for Diversity. For the fourth year in a row, Novartis Pharmaceuticals Corporation has been recognized ...
